Dabigza 150 Capsule is an anticoagulant or blood thinner. It helps prevent and treat blood clots. It is used to reduce the risk of stroke and heart attack. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart.

Dabigza 150 Capsule is commonly used in patients with irregular heart rhythm (atrial fibrillation) to prevent clot formation. It also reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. It can be taken with or without food, but it is best to take them at the same time each day. You may need to take this medicine for many years, even for life in some cases. Do not stop taking it or change the dose without guidance from your doctor. It could quickly put you more at risk of having a heart attack, stroke, or thrombosis (formation of a blood clot within a blood vessel). You can reduce your risk of having a blood clot by making changes to your lifestyle, such as not smoking, eating a healthy diet, getting regular exercise, and losing weight if you need to.

The most common side effect of Dabigza 150 Capsule are stomach upset and bleeding more easily than normal, for example having nosebleeds or bruising. If you experience any symptoms, tell your doctor immediately. Other side effects include headaches, seizures, allergic reactions, changes to your eyesight, and tiredness.

Do not take this medicine if you have severe kidney or liver problems, if you are currently bleeding or if you are taking other medicines to reduce blood clotting. You should not breastfeed while using this medicine. Unlike other anticoagulants, a regular blood test (PT-INR) is not required while taking this medicine.

Uses of Dabigza Capsule

Treatment and prevention of Blood clots
Deep vein thrombosis
Pulmonary embolism
Stroke

Benefits of Dabigza Capsule

In Treatment and prevention of Blood clots

Dabigza 150 Capsule is a type of medicine known as an anticoagulant. Although it does not “dissolve” blood clots, it can prevent them from getting bigger so your body can dissolve them over time. It will also prevent new ones from forming. It works by blocking a substance in the body which is involved in blood clotting. This keeps your blood flowing freely around your body and makes it less likely that a clot will form inside a blood vessel. This can help prevent or reduce damage caused by stroke, clots in your lungs (pulmonary embolism), or other blood vessels (thrombosis). It can also make it less likely that parts of a clot will break off and travel to other parts of the body. You should take it regularly and make appropriate lifestyle changes to help this medicine be effective.

Side effects of Dabigza Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Dabigza

Nausea
Anemia (low number of red blood cells)
Gastrointestinal bleeding
Dyspepsia
Diarrhea
Abdominal pain
Nosebleeds
Skin bleeding

How to use Dabigza Capsule

Take this medicine in the dose and duration as advised by your doctor. Dabigza 150 Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Dabigza Capsule works

Dabigza 150 Capsule is a novel oral anticoagulant (NOAC). It works by preventing the formation of blood clots in the body.

Safety advice

Alcohol

UNSAFE

It is unsafe to consume alcohol with Dabigza 150 Capsule.

Pregnancy

CONSULT YOUR DOCTOR

Dabigza 150 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Dabigza 150 Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

SAFE

Dabigza 150 Capsule does not usually affect your ability to drive.

Kidney

CAUTION

Dabigza 150 Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Dabigza 150 Capsule may be needed. Please consult your doctor.
Use of Dabigza 150 Capsule is not recommended in patients with severe kidney disease.

Liver

CAUTION

Dabigza 150 Capsule should be used with caution in patients with liver disease. Dose adjustment of Dabigza 150 Capsule may be needed. Please consult your doctor.

What if you forget to take Dabigza Capsule?

If you missed a dose of Dabigza 150 Capsule, take it as soon as possible on the same day. The missed dose should be skipped if it cannot be taken at least 6 hours before the next scheduled dose. Do not double the dose to make up for a missed dose.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Dabigza 150 Capsule

₹26.7/Capsule

Dabigo 150mg Capsule

Sun Pharmaceutical Industries Ltd

₹17.2/capsule

36% cheaper

Pradaxa 150mg Capsule

Boehringer Ingelheim

₹39/capsule

46% costlier

Dabistar 150 Capsule

Lupin Ltd

₹37/capsule

39% costlier

Afogatran 150 Capsule

Torrent Pharmaceuticals Ltd

₹39.4/capsule

48% costlier

Dablexa 150 Capsule

Abbott

₹39.4/capsule

48% costlier

View all substitutes

Quick tips

Take it as per dose and duration suggested by your doctor.
Dabigza 150 Capsule increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g., football and wrestling).
If you are going to have a surgery or dental treatment, you may be asked to stop taking Dabigza 150 Capsule temporarily.
Your doctor may get a blood test done to check kidney function before starting treatment with this medicine.
Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Do not stop taking the medication without talking to your doctor.
You have been prescribed Dabigza 150 Capsule to help prevent blood clots
For best results, take it at the same time every day.
Unlike other similar medications, regular lab tests are not required (PT-INR).
It interacts less with food or other medicines. Hence, frequent dose changes are not required.
Dabigza 150 Capsule increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g., football and wrestling).
Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).
Notify your doctor if you have any kidney problem.
If you are going to have a surgery or dental treatment, you may be asked to stop taking Dabigza 150 Capsule temporarily.

Fact Box

Chemical Class

Benzimidazole derivative

Habit Forming

Therapeutic Class

CARDIAC

Action Class

Oral Direct Thrombin Inhibitors

Interaction with drugs

Taking Dabigza with any of the following medicines can modify the effect of either of them and cause some undesirable side effects

Fluconazole (Injection Route) Severe

Fluconazole may raise blood levels of Dabigatran Etexilate. If concurrent use is essential, watch out for bleeding and consult your doctor immediately. They may discontinue Dabiga... More

Amiodarone (Oral Route) Severe

Amiodarone may raise blood levels of Dabigatran Etexilate. Watch out for symptoms of anemia or bleeding, and consult your doctor if you experience them. Your doctor may discontinu... More

Amiodarone (Injection Route) Severe

Amiodarone may raise blood levels of Dabigatran Etexilate. Watch out for symptoms of anemia or bleeding, and consult your doctor if you experience them. Your doctor may discontinu... More

Fluconazole (Oral Route) Severe

Fluconazole may raise blood levels of Dabigatran Etexilate. If concurrent use is essential, watch out for bleeding and consult your doctor immediately. They may discontinue Dabiga... More

Fosphenytoin (Injection Route) Severe

Fosphenytoin may reduce blood levels of Dabigatran Etexilate. Do not consume Dabigatran Etexilate with Fosphenytoin.

View all drug interactions

Patient concerns

Deep vein thrombosis , swelling nd painful in both leg.

Dr. Sunil Sekhri

Diabetology

You need to take a surgical consultation

Looking for a specialist in Deep vein thrombosis preferably in Kochi

Dr. Nabajit Talukdar

Cardiology

See a vascular surgeon

FAQs

When should I take Dabigza 150 Capsule?

Mostly, Dabigza 150 Capsule is suggested to be taken twice daily at the same time each day. The two doses should be taken at a gap of about 12 hours.

Can I drink alcohol with Dabigza 150 Capsule?

Taking alcohol while taking Dabigza 150 Capsule can increase the effect of this medicine, thereby increasing the chance of bleeding. Regular intake of alcohol can lead to a gastric ulcer which might again cause bleeding. So, it is better to avoid alcohol while you are taking this medicine. Do consult your doctor if any such episode of bleeding occurs.

Can Dabigza 150 Capsule cause hair loss?

As compared to other blood-thinning medications, Dabigza 150 Capsule does not usually cause hair loss. However, there do exist some rare reports of hair loss associated with Dabigza 150 Capsule. Consult your doctor if you face hair loss while taking Dabigza 150 Capsule to rule out any other causes of hair loss.

When will I feel better after taking Dabigza 150 Capsule?

Dabigza 150 Capsule reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Dabigza 150 Capsule. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.

Does Dabigza 150 Capsule affect the liver?

Unlike other anticoagulants, Dabigza 150 Capsule usually does not affect the functioning of the liver. But long-term use of Dabigza 150 Capsule may increase the chances of mild liver injury in patients with elevated liver enzymes. However, the overall chances of developing any such problem are lower than other anticoagulants. It is advised that you inform your doctor if you have a history of liver disease before starting this medicine.

How should I store Dabigza 150 Capsule?

Dabigza 150 Capsule should be stored at room temperature between 59°F to 86°F (15°C to 30°C). Store the medicine at a dry place and protect the capsules from moisture. Close the bottle tightly after use and keep it out of the reach of children. Once the bottle is opened, it should be used within 4 months. If unused within 4 months, please discard them safely.

Can the use of Dabigza 150 Capsule increase the risk of bleeding?

Yes, Dabigza 150 Capsule increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.

Who should not take Dabigza 150 Capsule?

People experiencing any unusual bleeding or people allergic to Dabigza 150 Capsule should not take it. Dabigza 150 Capsule should also be avoided by people with artificial (prosthetic) heart valves. Therefore, inform your doctor if you have ever had or plan to have a valve in your heart replaced.

Show less

Related lab tests

Activated Partial Thromboplastin Time

Complete Blood Count

Platelet Count

Prothrombin Time

Related ayurvedic ingredients

Fish Oil

Ginkgo biloba

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 865-66.
Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 594.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 346-47.
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 363-65.
Dabigatran etexilate mesylate. Ridgefield, Connecticut: Boehringer Ingelheim Pharmaceuticals, Inc.; 2010 [revised Nov. 2015]. [Accessed 15 Mar. 2019] (online) Available from:
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Dabigatran. [Updated 2020 Jan 20]. [Accessed 19 Feb. 2020] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). Dabigatran Etexilate. [Accessed 15 Mar. 2019] (online) Available from:
Dabigatran Etexilate [Prescribing Information]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2021. [Accessed 16 Jun. 2023] (online) Available from:

Marketer details

Name: Glenmark Pharmaceuticals Ltd

Address: Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.